Literature DB >> 18181692

Introduction: the realities of antiretroviral therapy rollout: overcoming challenges to successful programmatic implementation.

Bisola Ojikutu1.   

Abstract

In 2006, 2 million human immunodeficiency virus (HIV)-infected people living in low- to middle-income countries were receiving antiretroviral therapy (ART). Although this is an improvement over previous years, significant operational challenges have inhibited progress toward universal access to HIV care and treatment. Despite these challenges, the intense efforts focused on addressing the HIV epidemic present an opportunity for overall health systems improvement in developing nations. In October 2006, Harvard University's Centers for AIDS Research, the Nelson Mandela School of Medicine, the Department of Health of KwaZulu-Natal, and the Medical Research Council of South Africa held a conference entitled "The Realities of Antiretroviral Therapy Rollout: Challenges to Successful Programmatic Implementation" in Durban, South Africa. The goal of the meeting was to bring together international and local leadership, including policy makers, health care workers, and funders, to propose an agenda that would address the challenges to more expeditious provision of HIV care and treatment in resource-limited settings.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18181692     DOI: 10.1086/521123

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

Review 1.  The spread, treatment, and prevention of HIV-1: evolution of a global pandemic.

Authors:  Myron S Cohen; Nick Hellmann; Jay A Levy; Kevin DeCock; Joep Lange
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

2.  A systematic review of task- shifting for HIV treatment and care in Africa.

Authors:  Mike Callaghan; Nathan Ford; Helen Schneider
Journal:  Hum Resour Health       Date:  2010-03-31

3.  Packaging PrEP to Prevent HIV: An Integrated Framework to Plan for Pre-Exposure Prophylaxis Implementation in Clinical Practice.

Authors:  Kristen Underhill; Don Operario; Margie Skeer; Matthew Mimiaga; Ken Mayer
Journal:  J Acquir Immune Defic Syndr       Date:  2010-09       Impact factor: 3.731

4.  A novel immunodominant CD8+ T cell response restricted by a common HLA-C allele targets a conserved region of Gag HIV-1 clade CRF01_AE infected Thais.

Authors:  Supranee Buranapraditkun; Ursula Hempel; Patrawadee Pitakpolrat; Rachel L Allgaier; Pattarawat Thantivorasit; Sven-Iver Lorenzen; Sunee Sirivichayakul; William H Hildebrand; Marcus Altfeld; Christian Brander; Bruce D Walker; Praphan Phanuphak; Pokrath Hansasuta; Sarah L Rowland-Jones; Todd M Allen; Kiat Ruxrungtham
Journal:  PLoS One       Date:  2011-08-22       Impact factor: 3.240

5.  HIV-infected children in rural Zambia achieve good immunologic and virologic outcomes two years after initiating antiretroviral therapy.

Authors:  Janneke H van Dijk; Catherine G Sutcliffe; Bornface Munsanje; Pamela Sinywimaanzi; Francis Hamangaba; Philip E Thuma; William J Moss
Journal:  PLoS One       Date:  2011-04-28       Impact factor: 3.240

6.  Digital depression screening in HIV primary care in South Africa: mood in retroviral + application monitoring [MIR + IAM].

Authors:  R V Passchier; S E Owens; M N Wickremsinhe; N Bismilla; I D Ebuenyi
Journal:  Glob Ment Health (Camb)       Date:  2019-01-28

7.  Barriers to the care of HIV-infected children in rural Zambia: a cross-sectional analysis.

Authors:  Janneke H van Dijk; Catherine G Sutcliffe; Bornface Munsanje; Francis Hamangaba; Philip E Thuma; William J Moss
Journal:  BMC Infect Dis       Date:  2009-10-16       Impact factor: 3.090

Review 8.  Combination prevention: new hope for stopping the epidemic.

Authors:  Sten H Vermund; Richard J Hayes
Journal:  Curr HIV/AIDS Rep       Date:  2013-06       Impact factor: 5.071

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.